HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22

Mucosal Immunology

Volumn 3, Issue 6, 2010, Pages 594-601

  Bodd, M ^a   Raki M ^a   Tollefsen, S ^a   Fallang, L E ^a   Bergseng, E ^a   Lundin, K E A ^a   Sollid, L M ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; GLIADIN; GLUTEN; HLA DQ2 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; MESSENGER RNA; TETRAMER;

ARTICLE; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; INTESTINE BIOPSY; LYMPHOCYTE CULTURE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROVOCATION TEST; STAINING;

EID: 77958169377     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.36     Document Type: Article

References (29)

1. Dickson, B. C., Streutker, C. J. & Chetty, R. Coeliac disease: an update for pathologists. J. Clin. Pathol. 59, 1008-1016 (2006).
2. Molberg, Ø. et al. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand. J. Immunol. 46, 103-108 (1997).
3. Tollefsen, S. et al. HLA-DQ2 and-DQ8 signatures of gluten T cell epitopes in celiac disease. J. Clin. Invest. 116, 2226-2236 (2006).
4. Qiao, S. W. et al. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. J. Immunol. 175, 254-261 (2005).
5. Molberg, Ø. et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4, 713-717 (1998).
6. van de Waal, Y. et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol. 161, 1585-1588 (1998).
7. *02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum. Immunol. 64, 469-477 (2003).
8. Jabri, B. & Sollid, L. M. Mechanisms of disease: immunopathogenesis of celiac disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 516-525 (2006).
9. O'Shea, J. J. & Paul, W. E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102 (2010).
10. Nilsen, E. M. et al. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37, 766-776 (1995).
11. Gianfrani, C. et al. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J. Immunol. 177, 4178-4186 (2006).
12. Castellanos-Rubio, A. et al. TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin. Autoimmunity 42, 69-73 (2009).
13. Monteleone, I. et al. Characterization of IL-17A-producing cells in celiac disease mucosa. J. Immunol. 184, 2211-2218 (2010).
14. Raki, M. et al. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc. Natl. Acad. Sci. USA 104, 2831-2836 (2007).
15. Anderson, R. P. et al. T cells in peripheral blood after gluten challenge in coeliac disease. Gut 54, 1217-1223 (2005).
16. Olsen, I. et al. Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4T cells from intestinal biopsies of Crohn's disease patients. PLoS ONE 4, e5641 (2009).
17. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V. K. IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485-517 (2009).
18. Fazilleau, N., Mark, L., Heyzer-Williams, L. J. & Heyzer-Williams, M. G. Follicular helper T cells: lineage and location. Immunity 30, 324-335 (2009).
19. Suto, A. et al. Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med. 205, 1369-1379 (2008).
20. Fina, D. et al. Interleukin-21 contributes to the mucosal T helper cell type 1 response in celiac disease. Gut 57, 887-892 (2007).
21. Roark, C. L., Simonian, P. L., Fontenot, A. P., Born, W. K. & O'Brien, R. L. Gammadelta T cells: an important source of IL-17. Curr. Opin. Immunol. 20, 353-357 (2008).
22. Ferretti, S., Bonneau, O., Dubois, G. R., Jones, C. E. & Trifilieff, A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170, 2106-2112 (2003).
23. Bettelli, E., Korn, T., Oukka, M. & Kuchroo, V. K. Induction and effector functions of T (H) 17 cells. Nature 453, 1051-1057 (2008).
24. De Nitto, D., Monteleone, I., Franze, E., Pallone, F. & Monteleone, G. Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease. World J. Gastroenterol. 15, 4609-4614 (2009).
25. van Heel, D. A. et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 39, 827-829 (2007).
26. Rostom, A., Murray, J. A. & Kagnoff, M. F. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 131, 1981-2002 (2006).
27. Molberg, Ø., McAdam, S. N., Lundin, K. E. & Sollid, L. M. Studies of gliadin-specific T cells in celiac disease. In Celiac Disease. Methods and Protocols. (Marsh, M. N., ed) 105-124 (Humana, Totowa, NJ, USA, 2000).
28. Fallang, L. E. et al. Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM. J. Immunol. 181, 5451-5461 (2008).
29. Anderson, R. P., Degano, P., Godkin, A. J., Jewell, D. P. & Hill, A. V. In vivo antigen challenge in celiac disease identifies a single transglutaminasemodified peptide as the dominant A-gliadin T-cell epitope. Nat. Med. 6, 337-342 (2000).